Katsube Kousuke, Bishop Allen T, Friedrich Patricia F
Department of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
J Orthop Res. 2004 Nov;22(6):1290-5. doi: 10.1016/j.orthres.2004.05.005.
The methods and efficiency of gene transfer into rabbit saphenous artery were examined in this study. The purpose was to develop an animal model capable of evaluating the use of angiogenic gene therapy to revascularize necrotic bone more rapidly and completely than by surgical implantation of blood vessels alone. The success of transduction using adenovirus vectors, liposome/DNA complexes, and naked DNA was evaluated with delivery to both intra-luminal and adventitial sites. Intra-luminal and adventitial (extra-luminal) application was used for the viral and liposome methods. Naked DNA was evaluated only in the intra-luminal site, based upon previous reports. Relative transduction success was expressed as the percentage of total cells with beta-galactosidase activity. A 20-mm length of saphenous artery exposed surgically was targeted for lacZ gene transfer. Two days after transduction, the arteries were harvested and stained with X-gal for beta-galactosidase activity. The percentage of endothelial, media and adventitial cells with beta-galactosidase activity was determined. Intra-arterial injection of adenovirus vector transduced the largest amount of cells in all three areas of the vessel (endothelium, media and adventitia). The adenovirus vectors when applied to the adventitia only transduced adventitial cells. Following intra-arterial injection of liposome/DNA complexes transduction was detected only in endothelium. Extra-luminal liposome and intra-arterial naked DNA delivery resulted in no detectable gene transfer. Intra-arterial delivery of an adenovirus vector would likely provide optimal gene transfer for possible angiogenic gene therapy.
本研究检测了基因导入兔隐动脉的方法和效率。目的是建立一种动物模型,以评估血管生成基因治疗在使坏死骨血管再生方面,是否比单纯手术植入血管能更快速、更完全地实现血管再生。使用腺病毒载体、脂质体/DNA复合物和裸DNA进行转导,并将其导入管腔和外膜部位,以此评估转导的成功率。病毒和脂质体方法采用管腔内和外膜(管腔外)应用。根据先前的报道,裸DNA仅在管腔内部位进行评估。相对转导成功率以具有β-半乳糖苷酶活性的总细胞百分比表示。手术暴露的一段20毫米长的隐动脉作为lacZ基因转移的靶点。转导两天后,采集动脉并用X-gal染色以检测β-半乳糖苷酶活性。测定具有β-半乳糖苷酶活性的内皮细胞、中膜细胞和外膜细胞的百分比。动脉内注射腺病毒载体在血管的所有三个区域(内皮、中膜和外膜)转导的细胞数量最多。腺病毒载体仅应用于外膜时,仅转导外膜细胞。动脉内注射脂质体/DNA复合物后,仅在内皮中检测到转导。管腔外脂质体和动脉内裸DNA递送均未检测到基因转移。动脉内递送腺病毒载体可能为可能的血管生成基因治疗提供最佳的基因转移。